Pharma City SEZ Proximity

Blog
SEZ Proximity Check

Pharma City SEZ Proximity Check

19,333 acres at Mucherla/Kadthal, Rangareddy · Largest pharma zone in Asia · HYDRAA Risk Assessment

    What is Hyderabad Pharma City?

    Hyderabad Pharma City is a 19,333-acre (78.2 sq km) Special Economic Zone (SEZ) being developed at Mucherla, Kadthal, and Yacharam mandals in Rangareddy district, approximately 25 km south of Hyderabad's Outer Ring Road (ORR). It is the largest dedicated pharmaceutical manufacturing zone in Asia, being developed by the Telangana State Industrial Infrastructure Corporation (TSIIC). The project aims to create a world-class pharma manufacturing hub that will house bulk drug manufacturing units, API (Active Pharmaceutical Ingredient) production facilities, formulation plants, and pharma R&D centres. When fully operational, Pharma City is expected to generate 5.5 lakh direct and indirect jobs and attract investments exceeding Rs 64,000 crore.

    Location & Size

    19,333 acres (78.2 sq km) spread across Mucherla, Kadthal, and Yacharam mandals in Rangareddy district. Located about 25 km south of ORR via Tukkuguda/Bonguluru direction. Connected to NH-44, proposed RRR Phase-2 intersection, and proposed Airport Express Metro line.

    Implementing Agency

    TSIIC (Telangana State Industrial Infrastructure Corporation) is the implementing agency. Land acquisition is carried out under the RFCTLARR Act 2013 (Right to Fair Compensation and Transparency in Land Acquisition, Rehabilitation and Resettlement Act). Over 10,000 acres have already been acquired.

    What Will Be Built

    Bulk drug manufacturing units, API production facilities, formulation plants, pharma R&D centres, Common Effluent Treatment Plant (CETP), pharma testing labs, warehousing, logistics parks, residential townships for workers, and commercial zones for supporting services.

    Employment Impact

    Estimated to create 5.5 lakh (550,000) direct and indirect jobs when fully operational. This includes pharma manufacturing workers, R&D professionals, logistics staff, and employees in supporting commercial and residential infrastructure built around the SEZ.

    Environmental Clearance

    Environmental clearance has been obtained from the Ministry of Environment, Forest and Climate Change (MoEFCC). A Common Effluent Treatment Plant (CETP) is planned for treating industrial waste. However, concerns remain about groundwater contamination and air quality impact on surrounding villages.

    Compensation for Land Owners

    Compensation is determined under the RFCTLARR Act 2013: 4x the market value for rural land + solatium (100% additional) + R&R (Rehabilitation & Resettlement) package for affected families. Landowners who have received Section 11 notification will receive compensation at rates determined by the Collector.

    Pharma City Proximity Risk Zones

    Zone Distance Risk Level Impact
    Acquisition Zone Within SEZ boundary Land will be acquired TSIIC acquires land for pharma manufacturing. Compensation at 4x market value under RFCTLARR Act 2013 + solatium + R&R package. Cannot build or develop.
    Buffer Zone Within 1 km High risk Environmental buffer zones may restrict residential development. Pollution concerns. May be acquired for support infrastructure (roads, utilities, worker housing).
    Environmental Concern 1-3 km Moderate concern No acquisition risk but environmental impact possible. Groundwater contamination, air quality degradation. Check TSPCB clearance conditions. Residential value may be affected.
    Investment Zone 3-10 km Positive outlook No acquisition or environmental risk. Properties likely to appreciate 50-200% over 5-10 years. Satellite townships, commercial centres, and residential demand will increase.
    No Impact More than 10 km No impact No direct impact from Pharma City. Standard property rules apply. No acquisition, environmental, or investment effect from the SEZ.

    Villages Affected by Pharma City Land Acquisition

    The following villages in Rangareddy district are directly affected by the Pharma City SEZ land acquisition. Land owners in these villages have received or will receive Section 11 notification under the RFCTLARR Act 2013.

    Mucherla
    Kadthal
    Yacharam
    Mankhal
    Meerkhanpet
    Polepally
    Mekaguda
    Tondapally
    Veliminedu
    Kothur
    Gudur
    Peddakondur

    Pharma City Key Statistics

    Total Area

    19,333 acres (78.2 sq km) — the largest dedicated pharmaceutical manufacturing zone in Asia. Spread across multiple villages in Mucherla, Kadthal, and Yacharam mandals of Rangareddy district.

    Estimated Investment

    Over Rs 64,000 crore in total investment expected from global pharma companies, bulk drug manufacturers, and API production units when fully operational.

    Employment Generation

    5.5 lakh (550,000) direct and indirect jobs expected. Includes pharma manufacturing, R&D, logistics, and supporting commercial/residential services.

    Connectivity

    Connected via NH-44 spur road, proposed Regional Ring Road (RRR) Phase-2 intersection, and proposed Airport Express Metro extension. About 25 km south of the ORR.

    What Property Buyers Should Do

    Check Acquisition Notifications

    Visit the District Collector's office in Rangareddy or check the TSIIC website for Section 11 notifications covering your survey number. Any land within the Pharma City SEZ boundary will have a gazette notification for acquisition.

    Check Pahani & Revenue Records

    Download Pahani records from Bhu Bharati to check if the land has any acquisition notations. Also verify the land classification and ownership status before purchasing.

    Download Encumbrance Certificate

    Use our EC Download (IGRS) tool to check for government acquisition orders, court attachments, or pending litigation related to Pharma City land acquisition on the property.

    Verify Exact Distance

    Use Google Maps or commission a survey to measure the exact distance from the Pharma City SEZ boundary. Properties within 1-3 km may face environmental impact even without acquisition risk. Consider the wind direction and topography.

    Related Verification Tools

    GO 111 Zone Check

    Check if property is in Osmansagar/Himayatsagar catchment zone

    HYDRAA Risk Assessment

    Assess demolition risk near water bodies and FTL zones

    Metro Corridor Impact Check

    Check Metro Rail acquisition risk and TOD zone impact

    Hyderabad Pharma City SEZ: Complete Guide for Property Buyers

    What is Hyderabad Pharma City and Why Does It Matter for Property Buyers?

    Hyderabad Pharma City is a 19,333-acre (78.2 sq km) Special Economic Zone being developed at Mucherla, Kadthal, and Yacharam mandals in Rangareddy district, approximately 25 km south of Hyderabad's Outer Ring Road. It is the largest dedicated pharmaceutical manufacturing zone in Asia, being developed by the Telangana State Industrial Infrastructure Corporation (TSIIC). The project was conceived to consolidate Telangana's position as India's bulk drug manufacturing capital — Hyderabad already accounts for over 30% of India's pharmaceutical production.

    For property buyers, Pharma City has a dual impact. If your land falls within the SEZ boundary, it will be acquired by TSIIC — you cannot retain or develop it. Compensation is provided under the RFCTLARR Act 2013 at 4x the market value for rural land, plus solatium and an R&R package. However, if your property is 3-10 km from the boundary, it represents a significant investment opportunity as satellite townships, commercial centres, and residential demand will surge once Pharma City becomes operational.

    Land Acquisition Under RFCTLARR Act 2013

    The Right to Fair Compensation and Transparency in Land Acquisition, Rehabilitation and Resettlement Act 2013 (RFCTLARR Act) governs land acquisition for Pharma City. Under this Act, the process follows these steps: (1) Social Impact Assessment (SIA) study, (2) Preliminary notification under Section 11, (3) Survey of land and census of affected families, (4) Hearing of objections, (5) Declaration under Section 19, (6) Award by the Collector determining compensation, (7) Taking possession and payment of compensation.

    Compensation for rural land under the RFCTLARR Act is calculated as 4x the market value (as determined by the Collector) plus a solatium of 100% of the compensation amount. Affected families also receive an R&R (Rehabilitation and Resettlement) package that includes employment for at least one family member, a house or Rs 6.85 lakh for house construction, an annual subsistence allowance, and transportation costs. Court challenges may delay the acquisition process but rarely prevent it, as the project has been declared to serve a public purpose.

    Environmental Impact on Surrounding Areas

    While Pharma City has obtained environmental clearance from MoEFCC and plans to install a Common Effluent Treatment Plant (CETP), the scale of pharma manufacturing in a 19,333-acre zone raises legitimate environmental concerns for surrounding areas. Pharmaceutical manufacturing generates chemical waste, air emissions from API synthesis, and potential groundwater contamination through effluent seepage. Properties within 1-3 km of the Pharma City boundary may experience reduced air quality and should monitor groundwater quality through the Telangana State Pollution Control Board (TSPCB).

    The environmental buffer zone within 1 km of the boundary may face restrictions on residential development as the area is designated for support infrastructure. The TSPCB will impose conditions on industrial operations, but the cumulative effect of hundreds of pharma units operating simultaneously is a concern that property buyers in nearby villages should consider when evaluating long-term livability and property value.

    Investment Opportunity: The 3-10 km Ring

    Properties located 3-10 km from the Pharma City boundary represent what many real estate analysts consider the prime investment zone. These areas — including parts of Kadthal, Yacharam, Ibrahimpatnam, and Shadnagar — are outside the acquisition zone and environmental impact radius but are close enough to benefit from the massive employment generation (5.5 lakh jobs), improved infrastructure (new roads, metro extension, commercial centres), and residential demand from Pharma City workers and professionals.

    Historical precedents from other SEZ developments in India show that properties in the 3-10 km ring typically appreciate 50-200% over the 5-10 year period during which the SEZ becomes operational. Areas near Kadthal and Yacharam that are not in the acquisition zone are already seeing increased real estate activity. However, buyers should ensure their property has clear title, valid pattadar passbook, and is not in any government land classification before investing.

    Step-by-Step: How to Check If Your Property Is Affected

    1. Identify your survey number and village — Check your property documents for the survey number, sub-division number, and village name. These are the primary identifiers used in acquisition notifications.
    2. Check TSIIC and District Collector notifications — Visit the Rangareddy District Collector's office or TSIIC website to check if your survey number appears in any Section 11 or Section 19 notification related to Pharma City land acquisition.
    3. Download Pahani records — Use our Pahani Land Records tool to check if any acquisition notations have been entered in the revenue records for your survey number.
    4. Download the Encumbrance Certificate — Use our EC Download (IGRS) tool to check for government acquisition orders or court attachments on the property.
    5. Measure distance from the SEZ boundary — Use Google Maps to measure the straight-line distance from your property to the nearest point of the Pharma City SEZ boundary. Properties within 1 km face buffer zone restrictions; 1-3 km face environmental concerns.
    6. Consult a local property lawyer — If your property is within 3 km of the boundary or you have received any government notice, engage a property lawyer who is familiar with RFCTLARR Act proceedings and TSIIC acquisition cases.

    Key Takeaway

    Hyderabad Pharma City is a transformative project that will reshape the real estate landscape of southern Rangareddy district. If your land is within the SEZ boundary, acquisition is inevitable — focus on securing fair compensation under the RFCTLARR Act. If your property is within 1-3 km, be cautious about environmental impact and possible infrastructure acquisition. If you are 3-10 km away, you are in the investment sweet spot — Pharma City will bring jobs, infrastructure, and demand that will drive significant property appreciation. Beyond 10 km, there is no direct impact. In all cases, verify your property status through revenue records, ECs, and acquisition notifications before making any purchase or sale decision.

    Frequently Asked Questions

    What is Hyderabad Pharma City and where is it located?
    Hyderabad Pharma City is a 19,333-acre (78.2 sq km) Special Economic Zone being developed at Mucherla, Kadthal, and Yacharam mandals in Rangareddy district, approximately 25 km south of Hyderabad's Outer Ring Road. It is the largest dedicated pharmaceutical manufacturing zone in Asia. The project is being implemented by the Telangana State Industrial Infrastructure Corporation (TSIIC) and will house bulk drug manufacturing units, API production facilities, formulation plants, and pharma R&D centres.
    Will my land be acquired for Pharma City? How do I check?
    If your land falls within the 19,333-acre SEZ boundary in Mucherla, Kadthal, or Yacharam mandals, it will be acquired by TSIIC. To check, visit the Rangareddy District Collector's office for Section 11 notifications that list affected survey numbers. You can also download Pahani records from Bhu Bharati to check for acquisition notations, and download the Encumbrance Certificate from IGRS to check for government acquisition orders on your property.
    What compensation will I receive if my land is acquired?
    Under the RFCTLARR Act 2013, compensation for rural land is calculated at 4x the market value (as determined by the District Collector) plus a solatium of 100% of the compensation amount. Additionally, affected families receive an R&R (Rehabilitation and Resettlement) package that includes employment for at least one family member, a house or Rs 6.85 lakh for house construction, an annual subsistence allowance of Rs 36,000 for one year, and transportation costs. The total compensation is typically 8-10x the government guideline value.
    Can I challenge the land acquisition in court?
    Yes, landowners can challenge the acquisition in the High Court on grounds such as improper procedure, inadequate compensation, failure to conduct Social Impact Assessment, or violation of consent requirements. Court cases may delay the acquisition process, and some landowners have obtained stay orders. However, since Pharma City has been declared to serve a public purpose and environmental clearance has been obtained, courts rarely overturn the acquisition itself — they more commonly order enhanced compensation.
    Is it safe to buy property near Pharma City as an investment?
    Properties 3-10 km from the Pharma City boundary are considered the prime investment zone. These areas are outside the acquisition zone and environmental impact radius but close enough to benefit from employment generation (5.5 lakh jobs), improved infrastructure, and residential demand. However, ensure the property has clear title, valid pattadar passbook, and is not in any government land classification. Avoid properties within 1-3 km due to environmental concerns from pharma manufacturing. Properties within the SEZ boundary should not be purchased as they will be acquired.
    What are the environmental concerns around Pharma City?
    Pharmaceutical manufacturing generates chemical waste, air emissions from API synthesis, and potential groundwater contamination. While Pharma City has environmental clearance and plans a Common Effluent Treatment Plant (CETP), the cumulative impact of hundreds of pharma units is a concern. Properties within 1-3 km may experience reduced air quality and should monitor groundwater quality. The TSPCB (Telangana State Pollution Control Board) will regulate operations, but residents in nearby villages should be aware of potential long-term environmental impact.
    Which villages are affected by Pharma City land acquisition?
    The primary villages affected by Pharma City land acquisition include Mucherla, Kadthal, Yacharam, Mankhal, Meerkhanpet, Polepally, Mekaguda, Tondapally, Veliminedu, Kothur, Gudur, and Peddakondur in Rangareddy district. Over 10,000 acres have already been acquired from these villages. Remaining land acquisition is ongoing. If you own land in any of these villages, check with the Rangareddy District Collector for acquisition notifications covering your specific survey number.
    When will Pharma City become fully operational?
    Pharma City is being developed in phases. Initial infrastructure development (roads, utilities, CETP) is underway, and the first batch of anchor tenants are expected to begin construction once land allotments are finalized. Full operational status is expected to take 8-10 years from the start of infrastructure development, with phased manufacturing activity beginning earlier. The project's timeline has been affected by land acquisition delays and court challenges, but development is progressing. When fully operational, it will generate 5.5 lakh jobs and transform the southern Rangareddy district corridor.